Literature DB >> 28804130

Innate lymphoid cells: major players in inflammatory diseases.

Mikaël Ebbo1,2, Adeline Crinier1, Frédéric Vély1,3, Eric Vivier1,3.   

Abstract

Recent years have seen a marked increase in our understanding of innate lymphoid cells (ILCs). ILCs can be classified into different groups based on their similarity to T cell subsets in terms of their expression of key transcription factors and cytokine production. Various immunological functions of ILCs have been described, and increasing numbers of studies have implicated these cells in inflammatory disorders. Here, we detail the roles of ILCs in inflammatory diseases; we cover type 2 inflammatory diseases (such as asthma, chronic rhinosinusitis and atopic dermatitis), as well as inflammatory bowel diseases, psoriasis and other systemic or organ-specific inflammatory and autoimmune diseases. Future directions in the field are discussed, together with potential avenues of treatment.

Entities:  

Mesh:

Year:  2017        PMID: 28804130     DOI: 10.1038/nri.2017.86

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  140 in total

1.  Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial.

Authors:  Wolfgang Hueber; Bruce E Sands; Steve Lewitzky; Marc Vandemeulebroecke; Walter Reinisch; Peter D R Higgins; Jan Wehkamp; Brian G Feagan; Michael D Yao; Marek Karczewski; Jacek Karczewski; Nicole Pezous; Stephan Bek; Gerard Bruin; Bjoern Mellgard; Claudia Berger; Marco Londei; Arthur P Bertolino; Gervais Tougas; Simon P L Travis
Journal:  Gut       Date:  2012-05-17       Impact factor: 23.059

2.  Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

Authors:  Christoph S N Klose; Melanie Flach; Luisa Möhle; Leif Rogell; Thomas Hoyler; Karolina Ebert; Carola Fabiunke; Dietmar Pfeifer; Veronika Sexl; Diogo Fonseca-Pereira; Rita G Domingues; Henrique Veiga-Fernandes; Sebastian J Arnold; Meinrad Busslinger; Ildiko R Dunay; Yakup Tanriver; Andreas Diefenbach
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

3.  Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.

Authors:  Dinesh Khanna; Christopher P Denton; Angelika Jahreis; Jacob M van Laar; Tracy M Frech; Marina E Anderson; Murray Baron; Lorinda Chung; Gerhard Fierlbeck; Santhanam Lakshminarayanan; Yannick Allanore; Janet E Pope; Gabriela Riemekasten; Virginia Steen; Ulf Müller-Ladner; Robert Lafyatis; Giuseppina Stifano; Helen Spotswood; Haiyin Chen-Harris; Sebastian Dziadek; Alyssa Morimoto; Thierry Sornasse; Jeffrey Siegel; Daniel E Furst
Journal:  Lancet       Date:  2016-05-05       Impact factor: 79.321

4.  Prostaglandin D2 regulates human type 2 innate lymphoid cell chemotaxis.

Authors:  Jinny E Chang; Taylor A Doherty; Rachel Baum; David Broide
Journal:  J Allergy Clin Immunol       Date:  2013-11-05       Impact factor: 10.793

5.  Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice.

Authors:  L Y Drake; K Iijima; H Kita
Journal:  Allergy       Date:  2014-06-17       Impact factor: 13.146

6.  Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.

Authors:  Hai-Chon Lee; Mark B Headley; Yueh-Ming Loo; Aaron Berlin; Michael Gale; Jason S Debley; Nicholas W Lukacs; Steven F Ziegler
Journal:  J Allergy Clin Immunol       Date:  2012-09-13       Impact factor: 10.793

7.  Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP.

Authors:  Vassili Soumelis; Pedro A Reche; Holger Kanzler; Wei Yuan; Gina Edward; Bernhart Homey; Michel Gilliet; Steve Ho; Svetlana Antonenko; Annti Lauerma; Kathleen Smith; Daniel Gorman; Sandra Zurawski; Jon Abrams; Satish Menon; Terri McClanahan; Rene de Waal-Malefyt Rd; Fernando Bazan; Robert A Kastelein; Yong-Jun Liu
Journal:  Nat Immunol       Date:  2002-06-10       Impact factor: 25.606

8.  Cancer Immunosurveillance by Tissue-Resident Innate Lymphoid Cells and Innate-like T Cells.

Authors:  Saïda Dadi; Sagar Chhangawala; Benjamin M Whitlock; Ruth A Franklin; Chong T Luo; Soyoung A Oh; Ahmed Toure; Yuri Pritykin; Morgan Huse; Christina S Leslie; Ming O Li
Journal:  Cell       Date:  2016-01-21       Impact factor: 41.582

9.  Vagal Regulation of Group 3 Innate Lymphoid Cells and the Immunoresolvent PCTR1 Controls Infection Resolution.

Authors:  Jesmond Dalli; Romain A Colas; Hildur Arnardottir; Charles N Serhan
Journal:  Immunity       Date:  2017-01-05       Impact factor: 31.745

10.  IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells.

Authors:  Yuefeng Huang; Liying Guo; Jin Qiu; Xi Chen; Jane Hu-Li; Ulrich Siebenlist; Peter R Williamson; Joseph F Urban; William E Paul
Journal:  Nat Immunol       Date:  2014-12-22       Impact factor: 25.606

View more
  112 in total

1.  Pulmonary environmental cues drive group 2 innate lymphoid cell dynamics in mice and humans.

Authors:  Franz Puttur; Laura Denney; Lisa G Gregory; Juho Vuononvirta; Robert Oliver; Lewis J Entwistle; Simone A Walker; Mark B Headley; Ewan J McGhee; James E Pease; Matthew F Krummel; Leo M Carlin; Clare M Lloyd
Journal:  Sci Immunol       Date:  2019-06-07

2.  Transdifferentiation of tumor infiltrating innate lymphoid cells during progression of colorectal cancer.

Authors:  Shuo Wang; Yuan Qu; Pengyan Xia; Yi Chen; Xiaoxiao Zhu; Jing Zhang; Guan Wang; Yong Tian; Jianming Ying; Zusen Fan
Journal:  Cell Res       Date:  2020-05-04       Impact factor: 25.617

3.  Tissue-Resident Group 2 Innate Lymphoid Cells Differentiate by Layered Ontogeny and In Situ Perinatal Priming.

Authors:  Christoph Schneider; Jinwoo Lee; Satoshi Koga; Roberto R Ricardo-Gonzalez; Jesse C Nussbaum; Lucas K Smith; Saul A Villeda; Hong-Erh Liang; Richard M Locksley
Journal:  Immunity       Date:  2019-05-22       Impact factor: 31.745

Review 4.  The interplay between innate lymphoid cells and T cells.

Authors:  Marie Cherrier; Gayetri Ramachandran; Rachel Golub
Journal:  Mucosal Immunol       Date:  2020-07-10       Impact factor: 7.313

Review 5.  Dissecting human ILC heterogeneity: more than just three subsets.

Authors:  Yannick Simoni; Evan W Newell
Journal:  Immunology       Date:  2017-12-26       Impact factor: 7.397

Review 6.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

7.  Dichotomous regulation of group 3 innate lymphoid cells by nongastric Helicobacter species.

Authors:  John W Bostick; Yetao Wang; Zeli Shen; Yong Ge; Jeffrey Brown; Zong-Ming E Chen; Mansour Mohamadzadeh; James G Fox; Liang Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2019-11-18       Impact factor: 11.205

8.  Aryl Hydrocarbon Receptor Signaling Cell Intrinsically Inhibits Intestinal Group 2 Innate Lymphoid Cell Function.

Authors:  Shiyang Li; John W Bostick; Jian Ye; Ju Qiu; Bin Zhang; Joseph F Urban; Dorina Avram; Liang Zhou
Journal:  Immunity       Date:  2018-11-13       Impact factor: 31.745

9.  Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells.

Authors:  Satoshi Hirose; Mihoko Kato; Kati Tormanen; Pedram Shafiei Jahani; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

Review 10.  Modeling asthma: Pitfalls, promises, and the road ahead.

Authors:  Helene F Rosenberg; Kirk M Druey
Journal:  J Leukoc Biol       Date:  2018-02-16       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.